Quality of life and palliative care need in multiple system atrophy and progressive supranuclear palsy: a pilot study using quantitative and qualitative methods
L Wiblin - 2017 - theses.ncl.ac.uk
Background Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are
atypical Parkinsonian disorders which are rapidly progressive. The impact that Parkinsonian …
atypical Parkinsonian disorders which are rapidly progressive. The impact that Parkinsonian …
[PDF][PDF] Psychometric properties of Integrated Palliative Outcome Scale: Czech standardization and validation
K Vlckova, E Hoschlova, E Chroustova, M Loucka - 2020 - scholar.archive.org
Background Outcome measurement is an essential part of the evaluation of palliative care
and the measurements need to be reliable, valid and adapted to the culture in which they …
and the measurements need to be reliable, valid and adapted to the culture in which they …
[引用][C] Management of constipation in patients with Parkinson's
AJP Carrasco, L Timmermann, DJ Pedrosa
[PDF][PDF] and Parkinson's Disease
T Brudeka - researchgate.net
The etiology of Parkinson's disease (PD) is multifactorial, with genetics, aging, and
environmental agents all a part of the PD pathogenesis. Widespread aggregation of the α …
environmental agents all a part of the PD pathogenesis. Widespread aggregation of the α …
Palliative 20 Diseases
S Nair - Textbook of Neuroanesthesia and Neurocritical Care …, 2019 - books.google.com
Chronic neurological diseases are debilitating and difficult to manage and cause
considerable burden to both patients and carers. A spectrum of neurological diseases can …
considerable burden to both patients and carers. A spectrum of neurological diseases can …
Early Palliative Care in Real-World Clinical Practice: Effectiveness Regarding Quality of Life and Symptoms of Newly Diagnosed Advanced Cancer Outpatients in …
W Siemens, CL Orellana-Rios… - … Control Group Study …, 2019 - papers.ssrn.com
Background: The evidence for early palliative care (EPC) often lacks external validity. Real-
world clinical practice approaches are therefore urgently needed. This study aims to assess …
world clinical practice approaches are therefore urgently needed. This study aims to assess …
Palliative and end of life care provision for people with Parkinson's disease, Progressive Supranuclear Palsy & Multiple System Atrophy
CE Morris - 2019 - theses.ncl.ac.uk
Background Parkinson's Disease (PD), Progressive Supranuclear Palsy (PSP) and Multiple
System Atrophy (MSA) are incurable neurodegenerative conditions. A lack of palliative care …
System Atrophy (MSA) are incurable neurodegenerative conditions. A lack of palliative care …
Parkinson's Disease: Part 1 Disease Trajectory# 361.
D Estupinan, A Roche'-Green… - Journal of palliative …, 2018 - search.ebscohost.com
The article focuses on the history and trajectory of Parkinson's Disease (PD). It discusses the
complications in patients suffering from PD including levo-dopa-related treatment like …
complications in patients suffering from PD including levo-dopa-related treatment like …
[PDF][PDF] Parkinson's disease: if you can't change the outcome how can you qualify the journey
MHS Tosin, CAC Mecone, B Oliveira - Hos Pal Med Int Jnl, 2018 - researchgate.net
Parkinson's disease is the second most prevalent neurodegenerative disease in the world
population. It is incurable and affects people of all ages. The progressive worsening of motor …
population. It is incurable and affects people of all ages. The progressive worsening of motor …